European Life Sciences Perspective: Current Trends and Brexit Implications – Part 2

The life sciences industry is undergoing transformation across the globe and facing challenges and opportunities arising from the COVID-19 pandemic. In addition, the United Kingdom’s exit from the European Union has brought significant changes for the industry in relation to issues including pharmaceutical and medical device regulation, antitrust and competition, and corporate transactions.

Please join us for a two-part webinar series on key legal, employment, and regulatory trends and issues impacting the European life sciences market.

This second session will focus on employment, data privacy, and regulatory matters.